ACCUPRIL

This brand name is authorized in United States. It is also authorized in Australia, Canada, South Africa.

Active ingredients

The drug ACCUPRIL contains one active pharmaceutical ingredient (API):

1	Quinapril UNII 33067B3N2M - QUINAPRIL HYDROCHLORIDE
	Quinapril is a potent angiotensin-converting enzyme (ACE) inhibitor. The mode of action of quinapril in humans and animals is to inhibit circulating and tissue ACE activity, thereby decreasing vasopressor activity and aldosterone secretion.
	Read more about Quinapril

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
ACCUPRIL Film-coated tablet	MPI, US: SPL/Old	FDA, National Drug Code (US)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
C09AA06	Quinapril	C Cardiovascular system → C09 Agents acting on the renin-angiotensin system → C09A ACE inhibitors, plain → C09AA ACE inhibitors, plain
Discover more medicines within C09AA06

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	1968N, 1969P, 1970Q
CA	Health Products and Food Branch	01947664, 01947672, 01947680, 01947699
US	FDA, National Drug Code	0071-0527, 0071-0530, 0071-0532, 0071-0535
ZA	Health Products Regulatory Authority	W/7.1.3/361, W/7.1.3/362, W/7.1.3/363, W/7.1.3/364